Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Replacement of the Native Mitral Valve Using the ReValve System

NCT: NCT07601269 · RECRUITING

NCT IDNCT07601269
StatusRECRUITING
Start Date2026-04-26
SponsorReValve Solutions Inc. (INDUSTRY)
First posted
Last updated

Brief Summary

This study is to collect preliminary chronic information on performance and safety of the ReValve System.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑